LifeMD (LFMDP) Depreciation & Amortization (CF) (2012 - 2025)

LifeMD has reported Depreciation & Amortization (CF) for 10 years, with the latest figure at $255955.0 in Q4 2025.

• For the quarter ending Q4 2025, Depreciation & Amortization (CF) rose 77.58% year-over-year to $255955.0; the trailing twelve-month figure through Mar 2026 stood at $1.5 million (down 56.55% YoY), and the FY2025 full-year result was $865524.0, down 86.04% from the prior year.
• Depreciation & Amortization (CF) for Q4 2025 stood at $255955.0, down from $262747.0 in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $1.7 million in Q1 2025, with the low at $10695.0 in Q4 2021.
• Historically, Depreciation & Amortization (CF) has averaged $393570.5 across 5 years, with a median of $57666.0 in 2023.
• Annual changes were most pronounced in 2024 — Depreciation & Amortization (CF) surged 2974.84% — and 2025, when it sank 33.33%.
• LifeMD's Depreciation & Amortization (CF) stood at $10695.0 in 2021, then soared by 319.61% to $44877.0 in 2022, then climbed by 28.5% to $57666.0 in 2023, then soared by 149.94% to $144132.0 in 2024, then soared by 77.58% to $255955.0 in 2025.
• The last three Depreciation & Amortization (CF) figures came in at $255955.0 (Q4 2025), $262747.0 (Q3 2025), and $1.0 million (Q2 2025), per Business Quant data.